SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 53.47+0.3%Nov 28 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: smh who wrote (3396)4/10/2001 11:07:47 PM
From: Biomaven  Read Replies (3) of 52153
 
Personally, I have mixed feelings about Cramer and TSC. On biotech specifically, Cramer himself undoubtedly sucks. However, I fairly often find interesting stuff on TSC and so I glance at it pretty regularly. It's a different view into the world than you get other places and I've not infrequently picked up a useful nugget there that I've not seen elsewhere.

That said, I don't find TSC useful enough to actually pay, and I suspect the quality will decline some now that they've cut staff another notch and gone into a "pay for this real-time insightful commentary" gig.

Finally, Cramer was allegedly a classmate of mine back in '84, although I can't say I recollect his presence. But clearly the old school tie prevents me from saying anything too nasty. <g>

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News